Braun: $1B state investment in Indiana’s life sciences expected to create 100K jobs
Seeking to position Indiana as a global leader in agritechnology and life sciences, Gov. Mike Braun unveiled a lofty goal in a public announcement Tuesday morning.
Life Science & Biotech
-
IBJ Podcast: Here’s how BiomEdit raised $18.4M in a tough VC year
BiomEdit CEO Aaron Schacht talks about the strategy behind the round and the changes the animal health startup had to make to secure the money it needed to bring its first product to market,
Read More -
Lilly, IU sign clinical trial, research agreement worth up to $40M
Officials say the pact, facilitated by the Indianapolis-based IU Launch Accelerator for Biosciences, is the largest single industry-sponsored agreement in the school’s history.
Read More -
Q&A with Cory Lewis, whose emphasis on collaboration has driven INCOG’s rapid growth
Lewis sat down with IBJ to talk about his leadership style and the role of cycling in his life.
Read More -
Q&A with Elanco’s Jeff Simmons on blockbusters, challenges and growing up on a vineyard
Elanco opened the doors of its new headquarters at the former GM stamping plant site this week.
Read More
Articles
Indiana life sciences giant Philip Low dies at 78
Low founded seven companies based on intellectual property developed at Purdue, including Endocyte Inc., which he sold to Novartis Inc. in 2018 for $2.1 billion.
CICP launches fund aimed at making Indiana a chemistry hub
The Catalyst Scholars Fund is supported by a $69.4 million grant from Lilly Endowment Inc. to the CICP Foundation Inc. and matching commitments from participating universities.
Q&A: BiomEdit CEO goes behind the scenes of an $18.4M VC round
The animal health startup had fundraising success in 2025, a year in which investment deals were hard to come by.
Lilly signs $1.12B deal with Germany-based firm to develop hearing loss treatments
The agreement with Seamless is the latest in a series of purchases and partnerships Lilly has established to build a pipeline of genetic medicines.
Lilly in talks to buy Ventyx Biosciences for more than $1B, WSJ reports
Ventyx is a San Diego-based biotech that specializes in drugs for inflammatory diseases like Crohn’s and rheumatoid arthritis.
Eli Lilly set to back Aktis Oncology’s upsized $318M IPO
Clinical-stage biotechnology company Aktis Oncology increased the size of its initial public offering by 50% and drew interest from Indianapolis-based Lilly for $100 million of shares in the listing.
Lilly to open Gateway Labs site in Philadelphia
Since the first biotech incubator site opened in 2019, participating startups have collectively raised more than $3 billion.
Heartland BioWorks inks biomanufacturing workforce training agreement
The Bloomington-based Applied Research Institute, which manages Heartland BioWorks, said the agreement will position Indiana as a “central nexus for biomanufacturing training and innovation.”
Lilly CEO calls on state to boost power supply as company seeks to build supercomputer
David Ricks, speaking Thursday during a panel at the annual BioCrossroads Life Sciences Summit, also called for Purdue and Indiana universities to upgrade their lab facilities.
Purdue heads clinical trial for new canine cancer treatment
Researchers say the new treatment holds the potential to treat some dogs diagnosed with cancer without turning to more expensive traditional procedures such as radiation, chemotherapy or surgery.
Heartland BioWorks headquarters planned for 16 Tech
Heartland BioWorks was designated as a federal technology hub by the U.S. Department of Commerce in October 2023 to support growth in biomanufacturing innovation and workforce development.
Lilly to acquire California-based gene therapy company focused on age-related vision loss
The move continues the Indianapolis-based drugmaker’s investments in age-related diseases.
Pharmaceutical, life science industries drive trade surge between Indiana and Portugal
Indiana’s growing partnership with Portugal includes imports like rubber, plastics and chemicals, the latter of which is driven largely by pharmaceuticals, according to a Portuguese trade representative.
J&J lays out plan to splinter orthopedics business into separate company
The move leaves J&J focused on its pharmaceutical and MedTech segments, which make prescription drugs, contact lenses and technology to treat cardiovascular disease and help with surgeries.
Roche’s FDA-approved vitamin D test clears way for diagnostic growth
The new vitamin D test, to be distributed from the Swiss-based company’s Indianapolis hub, is the first such test using a mass spectrometry-based system to receive regulatory approval in the U.S.
Weight-loss drugs can cut future health costs. The fight is over who pays now.
Evidence from clinical trials shows that GLP-1s have benefits beyond weight loss, preventing related chronic conditions and ultimately blunting health-plan costs. But the savings might take decades, experts say.
Potential breakup of Corteva plants kernel of uncertainty
Ag giant Corteva Agriscience is reportedly mulling a split of its seed and pesticide businesses, a move that could alter the company’s presence in Indianapolis as well as the state’s agriculture industry.
Elanco reports pet parasite treatment quickly hit $100M blockbuster status
The sales momentum comes as Elanco prepares to open its $200 million-plus corporate campus next month on the west side of downtown Indianapolis.
Gayle Cook, philanthropist and co-founder of Cook companies, dies at 91
Gayle Cook was known for her work in historic preservation—most notably for spearheading the restoration and preservation of the West Baden Springs and French Lick resorts.